Details of the Drug

General Information of Drug (ID: DM0GS0Z)

Drug Name
MOv18IgE
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD ID
D0IM1B

References

1 ClinicalTrials.gov (NCT02546921) This First in Human Study of the New Therapeutic Antibody MOv18 IgE in Patients With Advanced Cancer.